These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16107196)
1. Anti-MRSA agents: under investigation, in the exploratory phase and clinically available. Bryskier A Expert Rev Anti Infect Ther; 2005 Aug; 3(4):505-53. PubMed ID: 16107196 [TBL] [Abstract][Full Text] [Related]
2. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Micek ST Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745 [TBL] [Abstract][Full Text] [Related]
3. Key considerations in the treatment of complicated staphylococcal infections. Jones RN Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084 [TBL] [Abstract][Full Text] [Related]
7. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study. Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313 [No Abstract] [Full Text] [Related]
11. [The Dutch MRSA policy should be retained]. Vlaminckx BJ; Troelstra A; van der Bruggen T Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011 [TBL] [Abstract][Full Text] [Related]
12. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. French GL J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922 [TBL] [Abstract][Full Text] [Related]
14. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates]. Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069 [TBL] [Abstract][Full Text] [Related]
15. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Klevens RM; Edwards JR; Tenover FC; McDonald LC; Horan T; Gaynes R; Clin Infect Dis; 2006 Feb; 42(3):389-91. PubMed ID: 16392087 [TBL] [Abstract][Full Text] [Related]
16. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Orrett FA Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397 [TBL] [Abstract][Full Text] [Related]
17. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Appelbaum PC Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720 [TBL] [Abstract][Full Text] [Related]
18. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. Hmouda H; Ben Salem C; Bouraoui K; Jemni L J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611 [No Abstract] [Full Text] [Related]